by MVG Consulting | Jul 27, 2021 | Featured, Industry News
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions... by MVG Consulting | Jul 21, 2021 | Featured, Industry News
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions... by MVG Consulting | Jul 15, 2021 | Featured, Industry News
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is...
by MVG Consulting | Jul 8, 2021 | Featured, Industry News
When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite...
